Here, we systematically reviewed the available scientific evidence of genetic variation on PCSK9 and assessed the efficacy of PCSK9 inhibitors in cardiovascular outcomes, including cardiovascular death, myocardial infarction, and stroke. Here, PCSK9 is linked to Stroke.